Clover Health Investments Cost of Goods Sold 2020-2024 | CLOV

Clover Health Investments cost of goods sold from 2020 to 2024. Cost of goods sold can be defined as the difference between beginning and ending inventories for tangible products resulting in an expense that reflects production and sales costs.
Clover Health Investments Annual Cost of Goods Sold
(Millions of US $)
2023 $1,776
2022 $3,454
2021 $1,551
2020 $590
2019 $447
Clover Health Investments Quarterly Cost of Goods Sold
(Millions of US $)
2024-06-30 $248
2024-03-31 $265
2023-12-31 $838
2023-09-30 $419
2023-06-30 $244
2023-03-31 $275
2022-12-31 $894
2022-09-30 $840
2022-06-30 $859
2022-03-31 $862
2021-12-31 $442
2021-09-30 $436
2021-06-30 $459
2021-03-31 $214
2020-12-31 $180
2020-09-30 $145
2020-06-30 $119
2020-03-31 $146
2019-12-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $1.696B $2.034B
Clover Health Investments Corp. is a healthcare technology company. It uses its proprietary technology platform to collect, structure and analyze health and behavioral data to improve medical outcomes and lower costs for patients. Clover Health Investments Corp., formerly known as Social Capital Hedosophia Holdings Corp. III, is based in Calif.
Stock Name Country Market Cap PE Ratio
Tempus AI (TEM) United States $11.384B 0.00
Inspire Medical Systems (INSP) United States $5.892B 183.76
Hims & Hers Health (HIMS) United States $5.028B 130.06
Axonics (AXNX) United States $3.600B 1760.50
IRhythm Technologies (IRTC) United States $2.707B 0.00
Enovis (ENOV) United States $2.594B 17.58
Privia Health (PRVA) United States $2.547B 213.00
Omnicell (OMCL) United States $2.306B 75.97
Azenta (AZTA) United States $2.190B 124.39
10x Genomics (TXG) United States $1.893B 0.00
Schrodinger (SDGR) United States $1.365B 0.00
Phreesia (PHR) United States $1.228B 0.00
Standard BioTools (LAB) United States $0.800B 0.00
Fulgent Genetics (FLGT) United States $0.589B 0.00
Butterfly Network (BFLY) United States $0.558B 0.00
Talkspace (TALK) United States $0.555B 0.00
Definitive Healthcare (DH) United States $0.500B 84.80
Health Catalyst (HCAT) United States $0.498B 0.00
Pulmonx (LUNG) United States $0.294B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.230B 0.00
TruBridge (TBRG) United States $0.203B 58.91
American Well (AMWL) United States $0.135B 0.00
P3 Health Partners (PIII) United States $0.134B 0.00
EUDA Health Holdings (EUDA) Singapore $0.108B 0.00
HeartBeam (BEAT) United States $0.068B 0.00
Future Health ESG (FHLT) United States $0.065B 0.00
111 (YI) China $0.059B 0.00
Zepp Health (ZEPP) China $0.049B 0.00
SHL Telemedicine (SHLT) Israel $0.045B 0.00
CareCloud (CCLD) United States $0.044B 0.00
Outset Medical (OM) United States $0.040B 0.00
Movano (MOVE) United States $0.029B 0.00
Bullfrog AI Holdings (BFRG) United States $0.021B 0.00
MSP Recovery (LIFW) United States $0.018B 0.00
Strata Skin Sciences (SSKN) United States $0.013B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.013B 0.00
Streamline Health Solutions (STRM) United States $0.011B 0.00
Precipio (PRPO) United States $0.009B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.008B 0.00
Healthcare Triangle (HCTI) United States $0.007B 0.00
Predictive Oncology (POAI) United States $0.005B 0.00
Syra Health (SYRA) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
HeartSciences (HSCS) United States $0.002B 0.00
Zhongchao (ZCMD) China $0.002B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00